Cidofovir 113852-37-2

inquire about Cidofovir
Cidofovir

Cidofovir is an injectable antiviral medication for the treatment of cytomegalovirus (CMV) retinitis

Uses

DNA virus

Cidofovir demonstrated a statistically significant effect in delaying the progression of CMV retinitis lesions in newly diagnosed patients, as well as in previously treated patients who had failed other therapies. Cidofovir has also shown efficacy in the treatment of acyclovir resistant herpesCidofovir has also been investigated as a treatment for progressive multifocal leukoencephalopathy, but {{As of

 

 

2005

 

 

lc=on

read more [+]
Systematic (IUPAC) name: ({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
Cidofovir CAS number: 113852-37-2
ATC code: J05AB12
PubChem: 60613
DrugBank: APRD00148
Formula: C8H14N3O6
Molecular mass: 279.187 g/mol
Cidofovir Assay/Purity: Typically NLT 98%
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.